Responsible for the development of Pricing, Reimbursement, Access (PRA) and Pharmacy Channel Distribution strategy for key U.S. Product launches. Responsible for leveraging extensive payer expertise to ensure U.S. payer input into product development planning for all therapeutic areas.

Responsible for the development of the Pricing, Reimbursement, and Access strategies in the U.S. Lead the creation of the brand Payer Value Message, Contracting Strategy (Managed Care, Medicare, and Medicaid), Payer Access marketing materials, and Patient Assistance Programs.

Responsible for Leading and Engaging a team of 14 Specialty (Biologic) Sales Representatives. Exceeded annual sales goal, earning top district national sales performance award. Effectively managed operating expense budget, developed a culture of team and patient first mentality, while coaching and leading the team through organizational change.

Led Cross-functional Healthcare Reform Steering Committee, which conducted financial analysis of impact of legislation on Lilly USA.Managed, analyzed and developed Medicare, Medicaid fee-for service, Medicaid managed care and other governmental program contracting strategies for Lilly USA brands.Created and launched Healthcare Reform segment specific overview tool kits, summarizing the Patient Protection and Affordable Care Act 2010 for managed care account managers, internal and external stakeholders.Conduced Healthcare Reform presentations for Managed Care customers nationwide, as Health Reform subject matter expert (Medicaid, Medicare Part D, Medicare Part D Coverage Gap Discount Program etc.).